Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial

Journal:

The Lancet

Published:

2025-10-24

DOI:

10.1016/s0140-6736(25)01571-5

Affiliations:

21

Authors:

64

Go to article

Institutions	Authors	Share
Seoul National University (SNU), South Korea	3.550000	0.14
Seoul National University Hospital (SNUH), South Korea	3.550000	0.14
Sejong General Hospital, South Korea	1.050000	0.04
Uijeongbu St. Mary's Hospital, South Korea	1.050000	0.04
Chungnam National University Hospital (CNU Hospital), CNU, South Korea	1.050000	0.04
Dankook University Hospital, South Korea	1.050000	0.04
Presbyterian medical center in Jeonju, South Korea	1.050000	0.04
Hallym University Sacred Heart Hospital, HUMC, South Korea	1.050000	0.04
Dongsan Medical Center, KMU, South Korea	1.050000	0.04
Ilsan Hospital, South Korea	1.050000	0.04
Chungbuk National University Hospital, South Korea	1.050000	0.04
Ewha Womans University Medical Center (EUMC), Ewha, South Korea	1.050000	0.04
Soon Chun Hyang University Hospital Seoul, SCH, South Korea	1.050000	0.04
Inje University Sanggye Paik Hospital, South Korea	1.050000	0.04
Hanyang University Seoul Hospital, South Korea	1.050000	0.04
GangNeung Asan Hospital, South Korea	1.050000	0.04
Gyeongsang National University Hospital, GNU, South Korea	1.050000	0.04
Jeonbuk National University Hospital, South Korea	1.050000	0.04
Gyeongsang National University Changwon Hospital, South Korea	1.050000	0.04
Chung-Ang University Hospital (CAUH), South Korea	1.050000	0.04

Interested in Cardiovascular Medicine and Haematology?